» Authors » Gerard Amarenco

Gerard Amarenco

Explore the profile of Gerard Amarenco including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 124
Citations 1137
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lallemant-Dudek P, Guillaud-Bataille M, Hentzen C, Joussain C, Pichon B, Robain G, et al.
Eur J Neurol . 2024 Dec; 32(1):e70003. PMID: 39704400
Background: The aim of this study was to characterize hereditary spastic paraplegias (HSP) patients' urodynamic profiles and development of bladder symptoms. Methods: This is a multicentric retrospective study which included...
2.
Hentzen C, Chesnel C, Lagnau P, Blouet E, Teng M, Amarenco G
Fr J Urol . 2024 Dec; :102847. PMID: 39701183
Purpose: This study aimed to assess the relationship between kinetics of bladder sensations perception, detrusor overactivity (DO), and severity of overactive bladder (OAB) symptoms in patients with multiple sclerosis (PwMS)....
3.
Cabrilo I, Hentzen C, Malladi P, Simeoni S, Amarenco G, Zaidman N, et al.
Eur J Neurol . 2024 Nov; 32(1):e16530. PMID: 39498736
Background And Purpose: Midline sacral meningeal cysts (MSMCs) are cerebrospinal fluid-filled dural diverticula. Although widely considered asymptomatic, cases involving voiding difficulties or pain have been reported. The aims of this...
4.
Hentzen C, Chesnel C, Lagnau P, Blouet E, Teng M, Amarenco G
World J Urol . 2024 Mar; 42(1):136. PMID: 38478090
Aims: The aims of the present study were to assess the effectiveness of transcutaneous tibial nerve stimulation (TTNS) on overactive bladder (OAB) symptoms and on urodynamic parameters in patients with...
5.
Mailho C, Peyronnet B, De Seze M, Even A, Perrouin-Verbe M, Amarenco G, et al.
Neurourol Urodyn . 2024 Mar; 43(4):811-817. PMID: 38451038
Introduction: Neurogenic detrusor overactivity (NDO) has a major impact on patients' quality of life and can lead to upper urinary tract complications. Intradetrusor botulinum toxin type A injections are administered...
6.
Khoury J, Hermieu N, Chesnel C, Xylinas E, Teng M, Ouzaid I, et al.
Neurourol Urodyn . 2024 Feb; 43(4):874-882. PMID: 38390751
Objective: Primary bladder neck obstruction (PBNO) is a condition primarily affecting young men, characterized by obstruction at the bladder neck, leading to lower urinary tract symptoms. The aim of this...
7.
Thiruchelvam N, Landauro M, Biardeau X, Rovsing C, Hahn M, Nascimento O, et al.
Neurourol Urodyn . 2024 Jan; 43(2):464-478. PMID: 38196237
Aims: To confirm the improved performance of the micro-hole zone catheter (MHZC) compared to a conventional eyelet catheter (CEC) in male users of clean intermittent catheterizations (CICs). Methods: Male self-catheterizing...
8.
Julienne A, Gourcerol G, Amarenco G, Turmel N, Leroi A, Desprez C
Clin Res Hepatol Gastroenterol . 2023 Dec; 48(2):102275. PMID: 38158155
Purpose: Three subtypes of fecal incontinence (FI) are described in the literature: urge, mixed and passive FI, but the relevance of this classification remains unknown. To our knowledge, no questionnaire...
9.
Leroi A, Queralto M, Zerbib F, Siproudhis L, Vitton V, Amarenco G, et al.
Lancet Gastroenterol Hepatol . 2023 Dec; 9(2):147-158. PMID: 38128556
Background: Non-randomised studies assessing intrarectal botulinum toxin type A (BoNTA) injections for faecal incontinence are promising. We aimed to evaluate the efficacy of BoNTA for the treatment of faecal incontinence...
10.
Chea M, Teng M, Chesnel C, Lagnau P, Amarenco G, Hentzen C
J Sex Med . 2023 Oct; 20(12):1407-1413. PMID: 37872743
Background: Postorgasmic illness syndrome (POIS) is a rare syndrome in which patients experience various physical and cognitive symptoms after ejaculation, and its pathophysiology remains unknown. Aim: The aim of this...